ProductGovernment / Research Program
CATALYST
ARPA-H's Computational ADME-Tox and Physiology Analysis for Safer Therapeutics program, offering up to $125 million to fund computational human-drug-safety models.
Made by ARPA-H
Covered in 1 article · July 2026
Coverage
Jul 19, 2026
ARPA-H Is Funding In Silico Drug Testing. Its Compute Footprint Is Still Opaque.
FDA is expanding non-animal methods while ARPA-H funds human drug-safety models. Public materials omit runtime, hardware, and deployment cost.
Jul 19, 2026 · By SCN Staff · 8 min read